We are live on ! Find out more
TWM

Thrive Wealth Management Portfolio holdings

AUM $787M
1-Year Est. Return 23.6%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+23.6%
3 Year Est. Return
+73.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$671M
AUM Growth
-$9.87M
Cap. Flow
+$14.2M
Cap. Flow %
2.12%
Top 10 Hldgs %
63.5%
Holding
261
New
23
Increased
88
Reduced
109
Closed
30

Top Buys

Rank Stock Value
1
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$12.3M
2
VTV icon
Vanguard Value ETF
VTV
+$5.95M
3
VUG icon
Vanguard Growth ETF
VUG
+$866K
4
CGMU icon
Capital Group Municipal Income ETF
CGMU
+$803K
5
IBM icon
IBM
IBM
+$802K

Top Sells

Rank Stock Value
1
COLL icon
Collegium Pharmaceutical
COLL
+$941K
2
LMT icon
Lockheed Martin
LMT
+$490K
3
DHR icon
Danaher
DHR
+$480K
4
TMO icon
Thermo Fisher Scientific
TMO
+$450K
5
AZN icon
AstraZeneca
AZN
+$413K

Sector Composition

Rank Sector Weight
1 Technology 7.02%
2 Financials 3.96%
3 Healthcare 2.81%
4 Communication Services 2.58%
5 Industrials 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONDS icon
226
Ondas Inc
ONDS
$3.91B
$118K 0.02%
+13,024
New +$142K
PUSA
227
Aureus Greenway Holdings
PUSA
$75.4M
$102K 0.02%
+30,000
New +$122K
EDIT icon
228
Editas Medicine
EDIT
$442M
$82.7K 0.01%
33,500
– –
CRBU icon
229
Caribou Biosciences
CRBU
$161M
$60.8K 0.01%
32,000
– –
BBAI icon
230
BigBear.ai
BBAI
$1.35B
$40.8K 0.01%
+11,589
New +$53.8K
OABI icon
231
OmniAb
OABI
$302M
$27.1K ﹤0.01%
17,281
– –
APP icon
232
Applovin
APP
$143B
– –
-408
Closed -$275K
AZN icon
233
AstraZeneca
AZN
$255B
– –
-2,247
Closed -$413K
BA icon
234
Boeing
BA
$165B
– –
-980
Closed -$213K
BEAM icon
235
Beam Therapeutics
BEAM
$2.71B
– –
-8,488
Closed -$235K
BIL icon
236
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
– –
-3,561
Closed -$325K
BOIL icon
237
ProShares Ultra Bloomberg Natural Gas
BOIL
$397M
– –
-5,000
Closed -$229K
BSY icon
238
Bentley Systems
BSY
$9.83B
– –
-5,739
Closed -$219K
CCI icon
239
Crown Castle
CCI
$34.1B
– –
-3,662
Closed -$325K
COLL icon
240
Collegium Pharmaceutical
COLL
$1.15B
– –
-20,326
Closed -$941K
COO icon
241
Cooper Companies
COO
$14B
– –
-3,774
Closed -$309K
CVS icon
242
CVS Health
CVS
$137B
– –
-2,673
Closed -$212K
GBTC icon
243
Grayscale Bitcoin Trust
GBTC
$9.79B
– –
-3,295
Closed -$225K
IBIT icon
244
iShares Bitcoin Trust
IBIT
$47.9B
– –
-5,067
Closed -$252K
IQV icon
245
IQVIA
IQV
$34B
– –
-968
Closed -$218K
IT icon
246
Gartner
IT
$9.44B
– –
-1,033
Closed -$261K
JKHY icon
247
Jack Henry & Associates
JKHY
$10.9B
– –
-1,680
Closed -$307K
MAIN icon
248
Main Street Capital
MAIN
$5.08B
– –
-5,073
Closed -$306K
MCO icon
249
Moody's
MCO
$88.3B
– –
-404
Closed -$207K
MDLV icon
250
Morgan Dempsey Large Cap Value ETF
MDLV
$42.2M
– –
-7,279
Closed -$206K
7 8 9
10
11

Similar funds

FAMI
Fideuram Asset Management (Ireland) Dublin 1 $787M AUM
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
RBC
Roble Belko & Company Sewickley, Pennsylvania $787M AUM 16.42% 1-Year Est. Return
SBCM
Schwerin Boyle Capital Management Springfield, Massachusetts $788M AUM 13.82% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
NEAM
New England Asset Management Farmington, Connecticut $786M AUM 13.14% 1-Year Est. Return
JSL
JT Stratford LLC Gainesville, Georgia $786M AUM 27.45% 1-Year Est. Return
LSPW
Lake Street Private Wealth Chicago, Illinois $785M AUM 21.47% 1-Year Est. Return

Thrive Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Thrive Wealth Management held 261 positions worth $671M, down 1.4% from $681M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Thrive Wealth Management's Q1 2026 filing shows 23 new, 88 increased, 109 reduced and 30 closed positions. Its largest new stake was Avantis International Equity ETF: 7,369 shares worth $625K. The largest sale was Collegium Pharmaceutical, an estimated $941K.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.6% a quarter earlier, followed by Financials and Healthcare.

  • Thrive Wealth Management's largest Q1 2026 buy was Avantis International Equity ETF: 7,369 shares worth $625K.
  • Thrive Wealth Management added most to Schwab US Large-Cap Growth ETF in Q1 2026, an estimated $12.3M increase.
  • Thrive Wealth Management's biggest Q1 2026 reduction was Lockheed Martin, cutting an estimated $490K.
  • Thrive Wealth Management fully exited Collegium Pharmaceutical in Q1 2026, selling an estimated $941K.
  • Thrive Wealth Management's ten largest holdings make up 64% of its $671M portfolio in Q1 2026.
  • Thrive Wealth Management opened 23 new positions and closed 30 in Q1 2026.
  • Thrive Wealth Management's portfolio value fell 1.4% quarter-over-quarter to $671M.

Based on Thrive Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.